SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics Corp. and DuPont Nutrition & Health (NYSE: DD) today announced a collaboration aimed at significantly improving food safety. The agreement, which includes a DuPont Ventures equity investment, gives DuPont worldwide, exclusive rights to AvidBiotics’ antibacterial protein technology in the broad realm of food and food protection. AvidBiotics retains all rights to applications of its technology in the fields of animal health, human therapeutics, human prophylactics and human diagnostics.
